🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study positron emission tomography (PET/CT) imaging will be used to...
Status
Terminated
Location
University of Pennsylvania Hospital
Start Date
2016-07
Trial ID
NCT02899533
Treatments Being Tested
FES PET/CT imaging for invasive lobular cancer...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2020-12-11
Trial ID
NCT04252859
Treatments Being Tested
Accurate staging is of great importance in patients with clinically locally...
Status
Completed
Location
VU University Medical Center
Start Date
2018-11-13
Trial ID
NCT03726931
Treatments Being Tested
The purpose of this study to compare two types of cancer imaging scans to s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2024-08-13
Trial ID
NCT06557148
Treatments Being Tested
A significant number of all invasive breast cancers are hormone sensitive a...
Status
Withdrawn
Location
Mallinckrodt Institute of Radiology
Start Date
2013-06
Trial ID
NCT01714128
Treatments Being Tested
To investigate the treatment pattern and efficacy of patients with negative...
Status
Completed
Location
China,Shanghai
Start Date
2023-09-01
Trial ID
NCT06344767
This study aimed to compare survival outcomes and clinical characteristics ...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-12-31
Trial ID
NCT07316439
This study aims to explore the diagnostic validity of \[18F\]FES PET/CT for...
Status
Completed
Location
Asan Medical Center
Start Date
2023-08-10
Trial ID
NCT05960201
Treatments Being Tested
CDK4/6 inhibitors are currently the standard treatment for female breast ca...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-05-15
Trial ID
NCT05861830
Despite broad advancements in endocrine therapy for ERα+ breast cancer, res...
Status
Recruiting
Location
University of Wisconsin Carbone Cancer Center
Start Date
2020-10-20
Trial ID
NCT04174352
Treatments Being Tested